Imaging PD-L1 Expression with ImmunoPET.

about

Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond Role of noninvasive molecular imaging in determining response

P2860

Q56891609-4C143C68-4328-427F-9CAE-413F1D63FE02 Q58119177-405E171E-9155-459B-A5B5-E6C1DB82141A

P2860

Imaging PD-L1 Expression with ImmunoPET.

Item

http://www.wikidata.org/entity/Q48324917

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Imaging PD-L1 Expression with ImmunoPET.

@en

Imaging PD-L1 Expression with ImmunoPET.

@nl

type

Item

label

Imaging PD-L1 Expression with ImmunoPET.

@en

Imaging PD-L1 Expression with ImmunoPET.

@nl

prefLabel

Imaging PD-L1 Expression with ImmunoPET.

@en

Imaging PD-L1 Expression with ImmunoPET.

@nl

P1476

Imaging PD-L1 Expression with ImmunoPET

@en

P2093

Albert J Chang

http://www.w3.org/2001/XMLSchema#string

Anna Moroz

http://www.w3.org/2001/XMLSchema#string

Benoit Jego

http://www.w3.org/2001/XMLSchema#string

Cheng-I Wang

http://www.w3.org/2001/XMLSchema#string

Chia-Yin Lee

http://www.w3.org/2001/XMLSchema#string

Collin Blakely

http://www.w3.org/2001/XMLSchema#string

Emilie Jaumain

http://www.w3.org/2001/XMLSchema#string

Hsueh Ling J Oh

http://www.w3.org/2001/XMLSchema#string

Junnian Wei

http://www.w3.org/2001/XMLSchema#string

Lawrence Fong

http://www.w3.org/2001/XMLSchema#string

P2860

High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells

High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.

NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer

Enhancement of antitumor immunity by CTLA-4 blockade

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies.

A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule

Imaging, Biodistribution, and Dosimetry of Radionuclide-Labeled PD-L1 Antibody in an Immunocompetent Mouse Model of Breast Cancer.

P304

96-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.BIOCONJCHEM.7B00631

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Charles Truillet

Charles S Craik

Khaled M Jami

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29125731

http://www.w3.org/2001/XMLSchema#string

P932

5773933

http://www.w3.org/2001/XMLSchema#string

Imaging PD-L1 Expression with ImmunoPET.

about

P2860

P2860

Imaging PD-L1 Expression with ImmunoPET.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932